摘要
目的:探讨抗胃癌单克隆抗体MG7、MGd1在卵巢粘液上皮肿瘤(OMET)组织中的表达与临床资料和患者预后的关系。方法:应用免疫组化SP法检测93份OMET组织中MG7、MGd1的表达,并对14a经手术切除、病理学检查证实的OMET患者的临床资料进行患者预后分析。结果:MG7、MGd1定位于OMET细胞膜及附近的胞浆,MG7在良性、交界性、恶性组表达率分别为0、80.65%、100%,MGd1分别为26.47%、96.77%、100%。3组间差异有显著性(P<0.05)。恶性组MG7过度表达率比MGd1者高14.28%。将本组OMET的临床资料、MG7和MGd1染色结果分别经COX风险模型分析,发现期别、肿瘤直径和MG7染色指标是影响患者预后的主要因素。OMETMG7表达(—)、(+)、()和()组的患者5a生存率分别为100%、72.37%、27.9%和13.13%,MGd1分别为(—)100%、(+)75.05%、()31.47%、()0.00%。结论:卵巢癌与胃癌组织间存在共同抗原性,具有同源性。MG7、MGd1对OMET的诊断有一定的特异性和敏感性,与临床病理分级、分类及预后有关,为OMET的?
Objective:To study the expressions of antigastric cancer monoclonal antibodies MG 7 and MGd 1 in ovarian mucinous epithelial tumors(OMET) and the relationship with clinical materials and patient's prognosis. Methods:93 specimens of OMET were collected to determine the expressions of monoclonal antibodies MG 7,MGd 1 by using immunohistochemical strepavidin peroxidase conjugated assay(SPCA), the correlation between clinical materials of the patients of 14 years after histopathologic identification and patient's prognosis of 93 cases had been analysed.Results:Monoclonal antibodies MG 7,MGd 1 localized on cytomembranes and their cytoplasma.Expressions of MG 7 in the specimens of benign,borderline,malignant OMET were 0、80.65%、100%.Those of MGd 1 were 26.47 %、96.77%、100% respectively.The differences among three groups were significant( P <0.05).In malignant group,overexpression of MG 7 was 14.28% higher than that of MGd 1.Clinical materials,expression of MG 7 and MGd 1 had been analysed by using COX harzards model and the clinical stage,tumor diameter,and staining of MG 7 were the main inflluence factors of patient's prognosis.MG 7 and MGd 1 expression degrees related with patient's 5 a survival rate.MGD 7 were (-)100%,(+)27.91%,()72.37%,()13.13%,MGD 1 were (-)100%,(+)75.05%,()31.47%,()0,sespectively.Conclusions:The results of this research show that gastric cancer and OMET tissues exist related antigen.There are higher sensitivity and specificity of MG 7 and MGd 1 expression in OMET,which is obviously related to patient's prognoses.It helps the classification and gradation of clinical pathology and provides a new means for early differential diagnosis of OMET.
出处
《现代妇产科进展》
CSCD
1998年第4期325-329,共5页
Progress in Obstetrics and Gynecology
基金
河北省自然科学基金
关键词
卵巢肿瘤
单克隆抗体
免疫组织化学
预后
Ovarian mucinous epithelial tumous
Antibodies
monoclonal
Immunohistochemistry
Patient's prognosis